Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts

Frontiers in Biology

Volumn 9, Issue 1, 2014, Pages 75-81

  Guan, Baoxiang ^a   Hoque, Ashraful ^a   Xu, Xiaochun ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

amiloride; cell viability; esophageal cancer; guggulsterone; NHE 1

Indexed keywords

MUS MUSCULUS;

EID: 84893789549     PISSN: 16747984     EISSN: 16747992     Source Type: Journal    
DOI: 10.1007/s11515-014-1289-z     Document Type: Article

References (29)

1. Blot W J (1994). Esophageal cancer trends and risk factors. Semin Oncol, 21(4): 403-410.
2. Chen X, Yang C S (2001). Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis, 22(8): 1119-1129.
3. Evans DM, Sloan Stakleff K D (2004). Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination. Clin Exp Metastasis, 21(4): 339-346.
4. Evans DM, Sloan-Stakleff K D, Arvan M, Guyton D P (1998). Time and dose dependency of the suppression of pulmonary metastases of rat mammary cancer by amiloride. Clin Exp Metastasis, 16(4): 353-357.
5. Falk G W (2009). Risk factors for esophageal cancer development. Surg Oncol Clin N Am, 18(3): 469-485.
6. Fitzgerald R C, Bishr Omary M, Triadafilopoulos G (1998). Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol, 275: 47-55.
7. Fitzgerald R C, Omary M B, Triadafilopoulos G (1997). Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci, 110(Pt 5): 663-671.
8. + exchanger. Mol Cell Biochem, 125(2): 137-143.
9. + exchanger-1 in esophageal epithelial defense against acid-induced injury. Am J Physiol Gastrointest Liver Physiol, 290(4): G665-G673.
10. Guan B X, Li H, Yang Z D, Hoque A, Xu X C (2013). Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts. Cancer, 119(7): 1321-1329.
11. Jaiswal K, Tello V, Lopez-Guzman C, Nwariaku F, Anthony T, Sarosi G A Jr (2004). Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line. Surgery, 136(2): 160-168.
12. Jenkins G J, Harries K, Doak S H, Wilmes A, Griffiths A P, Baxter J N, Parry J M (2004). The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis, 25(3): 317-323.
13. Jiang Z R, Gong J, Zhang Z N, Qiao Z (2006). Influence of acid and bile acid on ERK activity, PPARgamma expression and cell proliferation in normal human esophageal epithelial cells. World J Gastroenterol, 12(15): 2445-2449.
14. Li S, Bao P, Li Z, Ouyang H, Wu C, Qian G (2009). Inhibition of proliferation and apoptosis induced by a Na +/H + exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. Oncol Rep, 21(5): 1243-1249.
15. Loo S Y, Chang M K, Chua C S, Kumar A P, Pervaiz S, Clement M V (2012). NHE-1: a promising target for novel anti-cancer therapeutics. Curr Pharm Des, 18(10): 1372-1382.
16. Masereel B, Pochet L, Laeckmann D (2003). An overview of inhibitors of Na(+)/H(+) exchanger. Eur J Med Chem, 38(6): 547-554.
17. Menges M, Müller M, Zeitz M (2001). Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol, 96(2): 331-337.
18. Newell K, Wood P, Stratford I, Tannock I (1992). Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours. Br J Cancer, 66(2): 311-317.
19. Ouyang H, Bai X, Huang W, Chen D, Dohi S, Zeng W (2012). The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats. J Pain, 13(1): 41-48.
20. + exchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol, 42(1): 527-552.
21. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J, 14(14): 2185-2197.
22. + exchanger. Biochem Cell Biol, 80(5): 499-508.
23. Sparks R L, Pool T B, Smith N K R, Cameron I L (1983). Effects of amiloride on tumor growth and intracellular element content of tumor cells in vivo. Cancer Res, 43(1): 73-77.
24. Spechler S J (2005). Barrett's esophagus: a molecular perspective. Curr Gastroenterol Rep, 7(3): 177-181.
25. Tang J Y, Chang HW, Chang J G (2013). Modulating roles of amiloride in irradiation-induced antiproliferative effects in glioblastoma multiforme cells involving Akt phosphorylation and the alternative splicing of apoptotic genes. DNA Cell Biol, 32(9): 504-510.
26. Tatsuta M, Iishi H, Baba M, Uehara H, Nakaizumi A, Taniguchi H (1993). Inhibition by amiloride of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine inWistar rats. Br J Cancer, 67(5): 1011-1014.
27. Tatsuta M, Iishi H, Baba M, Yano H, Sakai N, Uehara H, Nakaizumi A (1997). Chemoprevention by amiloride against experimental hepatocarcinogenesis induced by Wnitrosomorpholine in Sprague-Dawley rats. Cancer Lett, 19(1): 109-113.
28. Xu X C (2009). Risk factors and altered gene expression in esophageal cancer. In: Verma M editor, Cancer Epidemiology. New York: Humana press, pp. 335-360.
29. Yamada T, Alpers D H, Laine L, Owyang C, Powell D W (1999). Textbook of gastroenterology. 3rd edition. Lippincott Williams and Wilkins: Philadelphia.